Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Karen Nelson, Robert Friedman, Jane Rogers, Mario Caccamo


The J. Craig Venter Institute has named Karen Nelson as president and Robert Friedman as chief operating officer. Both will report directly to J. Craig Venter, who will continue as CEO and chairman of the board of trustees.

Nelson has been with the institute since 1996 and was previously the director of its Rockville, Md.-based office and leader of the Human Genomic Medicine group. She will retain these duties.

Friedman joined JCVI in 2003 and will also maintain his current role as director of the San Diego facility and head of the Policy Group.

Jane Rogers, director of the UK's Genome Analysis Center, has decided to step down at the end of the year. Rogers has served as director for the past five years. Mario Caccamo, currently head of bioinformatics, has been appointed as deputy director and will temporarily lead the institute.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.